These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17555472)

  • 1. Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes.
    Germing U; Platzbecker U; Giagounidis A; Aul C
    Br J Haematol; 2007 Aug; 138(3):399-400. PubMed ID: 17555472
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet mass has prognostic value in patients with myelodysplastic syndromes.
    Bowles KM; Warner BA; Baglin TP
    Br J Haematol; 2006 Oct; 135(2):198-200. PubMed ID: 16939490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
    Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
    Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.
    Neukirchen J; Blum S; Kuendgen A; Strupp C; Aivado M; Haas R; Aul C; Gattermann N; Germing U
    Eur J Haematol; 2009 Nov; 83(5):477-82. PubMed ID: 19548919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM; Vasilache V; Bumbea H; Onisâi M
    Rom J Intern Med; 2011; 49(1):93-6. PubMed ID: 22026258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis.
    Sugimori N; Kondo Y; Shibayama M; Omote M; Takami A; Sugimori C; Ishiyama K; Yamazaki H; Nakao S
    Eur J Haematol; 2009 Jan; 82(1):54-60. PubMed ID: 18801060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
    Kao JM; McMillan A; Greenberg PL
    Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immature platelet fraction in patients with myelodysplastic syndromes. Association with poor prognosis factors.
    Larruzea Ibarra A; Muñoz Marín L; Perea Durán G; Torra Puig M
    Clin Chem Lab Med; 2019 May; 57(6):e128-e130. PubMed ID: 30352024
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet function in the myelodysplastic syndromes.
    Mittelman M; Zeidman A
    Int J Hematol; 2000 Feb; 71(2):95-8. PubMed ID: 10745619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French-American-British and World Health Organisation classifications.
    Breccia M; D'Elia GM; Cannella L; Stefanizzi C; Fama A; Federico V; Santopietro M; Alimena G
    Leuk Lymphoma; 2009 May; 50(5):841-3. PubMed ID: 19452321
    [No Abstract]   [Full Text] [Related]  

  • 11. Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
    Itzykson R; Crouch S; Travaglino E; Smith A; Symeonidis A; Hellström-Lindberg E; Sanz G; Čermák J; Stauder R; Elena C; Germing U; Mittelman M; Langemeijer S; Mądry K; Tatic A; Holm MS; Almeida AM; Savic A; Šimec NG; Luño E; Culligan D; Guerci-Bresler A; Malcovati L; van Marrewijk C; Bowen D; de Witte T; Fenaux P;
    Blood Adv; 2018 Aug; 2(16):2079-2089. PubMed ID: 30126931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood platelet function in chronic myeloid disorders. II. Myelodysplastic syndromes].
    Cieslar P; Matousová O
    Vnitr Lek; 1988 May; 34(5):441-8. PubMed ID: 3414027
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal leukocyte scattergrams and immature platelet fraction on Sysmex XN-9000 analyzer: a new diagnostic tool for altered megakaryopoiesis?
    Buoro S; Manenti B; Seghezzi M; Dominoni P; Vavassori M; Trezzi R; Galli M; Finazzi G
    Scand J Clin Lab Invest; 2017 Feb; 77(1):73-75. PubMed ID: 27937008
    [No Abstract]   [Full Text] [Related]  

  • 14. Down syndrome with myelodysplasia of megakaryoblastic lineage.
    Henderson R; Spence L
    Clin Lab Sci; 2006; 19(3):161-4. PubMed ID: 16910232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura.
    Ntaios G; Papadopoulos A; Chatzinikolaou A; Saouli Z; Karalazou P; Kaiafa G; Girtovitis F; Kontoninas Z; Savopoulos C; Hatzitolios A; Alexiou-Daniel S
    Acta Haematol; 2008; 119(3):173-7. PubMed ID: 18511864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective platelet aggregation in myelodysplastic syndromes.
    Girtovitis FI; Ntaios G; Papadopoulos A; Ioannidis G; Makris PE
    Acta Haematol; 2007; 118(2):117-22. PubMed ID: 17726306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in myelodysplastic syndromes].
    Kowal M
    Pol Arch Med Wewn; 1994 Oct; 92(4):338-46. PubMed ID: 7854962
    [No Abstract]   [Full Text] [Related]  

  • 18. Balloon-like platelets in myelodysplastic syndromes--a feature of dysmegakaryopoiesis?
    Widell S; Hast R
    Leuk Res; 1987; 11(8):747-52. PubMed ID: 3306168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ballooning platelets in the myelodysplastic syndromes (MDS).
    Jakobsen PE; Hansen JB; Pedersen JO; Jensen MK; Nielsen LC
    Eur J Haematol; 1994 Sep; 53(3):175-7. PubMed ID: 7925861
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet survival in myelodysplastic syndromes.
    Efira A; Cauchie P; Rauis M; de Maertelaere E
    Acta Haematol; 1986; 76(2-3):124-6. PubMed ID: 3101349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.